Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomy

Roger Li, Firas G. Petros, Janet B. Kukreja, Stephen Williams, John W. Davis

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The practice of extended pelvic lymph node dissection (ePLND) remains one of the most controversial topics in the management of clinically localized prostate cancer. Although most urologists agree on its benefit for staging and prognostication, the role of the ePLND in cancer control continues to be debated. The increased perioperative morbidity makes it unpalatable, especially in patients with low likelihood of lymph node disease. With the advent of robotic assisted laparoscopic prostatectomy, many surgeons were slow to adopt ePLND in the robotic setting. In this study, we summarize the evidence for the prognostic and therapeutic roles of ePLND, review the clinical tools used for lymph node metastasis prediction and survey the numerous experiences of ePLND compiled by robotic urologic surgeons over the years.

Original languageEnglish (US)
Pages (from-to)S155-S164
JournalInvestigative and Clinical Urology
Volume57
DOIs
StatePublished - 2016

Fingerprint

Prostatectomy
Lymph Node Excision
Robotics
Lymph Nodes
Prostatic Neoplasms
Neoplasm Metastasis
Morbidity
Neoplasms
Surgeons
Therapeutics

Keywords

  • Lymph node excision
  • Prostate neoplasms
  • Prostatectomy
  • Robotic surgical procedures

ASJC Scopus subject areas

  • Urology

Cite this

Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomy. / Li, Roger; Petros, Firas G.; Kukreja, Janet B.; Williams, Stephen; Davis, John W.

In: Investigative and Clinical Urology, Vol. 57, 2016, p. S155-S164.

Research output: Contribution to journalReview article

@article{ce815322c4804332a309b2e213848b8f,
title = "Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomy",
abstract = "The practice of extended pelvic lymph node dissection (ePLND) remains one of the most controversial topics in the management of clinically localized prostate cancer. Although most urologists agree on its benefit for staging and prognostication, the role of the ePLND in cancer control continues to be debated. The increased perioperative morbidity makes it unpalatable, especially in patients with low likelihood of lymph node disease. With the advent of robotic assisted laparoscopic prostatectomy, many surgeons were slow to adopt ePLND in the robotic setting. In this study, we summarize the evidence for the prognostic and therapeutic roles of ePLND, review the clinical tools used for lymph node metastasis prediction and survey the numerous experiences of ePLND compiled by robotic urologic surgeons over the years.",
keywords = "Lymph node excision, Prostate neoplasms, Prostatectomy, Robotic surgical procedures",
author = "Roger Li and Petros, {Firas G.} and Kukreja, {Janet B.} and Stephen Williams and Davis, {John W.}",
year = "2016",
doi = "10.4111/icu.2016.57.S2.S155",
language = "English (US)",
volume = "57",
pages = "S155--S164",
journal = "Investigative and Clinical Urology",
issn = "2466-0493",
publisher = "Korean Urological Association",

}

TY - JOUR

T1 - Current technique and results for extended pelvic lymph node dissection during robot-assisted radical prostatectomy

AU - Li, Roger

AU - Petros, Firas G.

AU - Kukreja, Janet B.

AU - Williams, Stephen

AU - Davis, John W.

PY - 2016

Y1 - 2016

N2 - The practice of extended pelvic lymph node dissection (ePLND) remains one of the most controversial topics in the management of clinically localized prostate cancer. Although most urologists agree on its benefit for staging and prognostication, the role of the ePLND in cancer control continues to be debated. The increased perioperative morbidity makes it unpalatable, especially in patients with low likelihood of lymph node disease. With the advent of robotic assisted laparoscopic prostatectomy, many surgeons were slow to adopt ePLND in the robotic setting. In this study, we summarize the evidence for the prognostic and therapeutic roles of ePLND, review the clinical tools used for lymph node metastasis prediction and survey the numerous experiences of ePLND compiled by robotic urologic surgeons over the years.

AB - The practice of extended pelvic lymph node dissection (ePLND) remains one of the most controversial topics in the management of clinically localized prostate cancer. Although most urologists agree on its benefit for staging and prognostication, the role of the ePLND in cancer control continues to be debated. The increased perioperative morbidity makes it unpalatable, especially in patients with low likelihood of lymph node disease. With the advent of robotic assisted laparoscopic prostatectomy, many surgeons were slow to adopt ePLND in the robotic setting. In this study, we summarize the evidence for the prognostic and therapeutic roles of ePLND, review the clinical tools used for lymph node metastasis prediction and survey the numerous experiences of ePLND compiled by robotic urologic surgeons over the years.

KW - Lymph node excision

KW - Prostate neoplasms

KW - Prostatectomy

KW - Robotic surgical procedures

UR - http://www.scopus.com/inward/record.url?scp=85006319286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006319286&partnerID=8YFLogxK

U2 - 10.4111/icu.2016.57.S2.S155

DO - 10.4111/icu.2016.57.S2.S155

M3 - Review article

AN - SCOPUS:85006319286

VL - 57

SP - S155-S164

JO - Investigative and Clinical Urology

JF - Investigative and Clinical Urology

SN - 2466-0493

ER -